These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 37842888)

  • 21. Monkeypox infection: The past, present, and future.
    Upadhayay S; Arthur R; Soni D; Yadav P; Navik U; Singh R; Gurjeet Singh T; Kumar P
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109382. PubMed ID: 36330915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repurposing of the antibiotic nitroxoline for the treatment of mpox.
    Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J
    J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into monkeypox pathophysiology, global prevalence, clinical manifestation and treatments.
    Niu L; Liang D; Ling Q; Zhang J; Li Z; Zhang D; Xia P; Zhu Z; Lin J; Shi A; Ma J; Yu P; Liu X
    Front Immunol; 2023; 14():1132250. PubMed ID: 37026012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive review of monkeypox virus and mpox characteristics.
    Alakunle E; Kolawole D; Diaz-Cánova D; Alele F; Adegboye O; Moens U; Okeke MI
    Front Cell Infect Microbiol; 2024; 14():1360586. PubMed ID: 38510963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
    Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
    Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review.
    Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK
    Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates.
    Prévost J; Sloan A; Deschambault Y; Tailor N; Tierney K; Azaransky K; Kammanadiminti S; Barker D; Kodihalli S; Safronetz D
    Antiviral Res; 2024 Nov; 231():105995. PubMed ID: 39243894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monkeypox: epidemiology, pathogenesis, treatment and prevention.
    Huang Y; Mu L; Wang W
    Signal Transduct Target Ther; 2022 Nov; 7(1):373. PubMed ID: 36319633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Human Mpox Global Outbreak: Available Control Tools and the Opportunity to Break a Cycle of Neglect in Endemic Countries.
    Nachega JB; Mbala-Kingebeni P; Rosenthal PJ; Rimoin AW; Hoff NA; Liesenborghs L; Vanlerberghe V; Andrei G; Rawat A; Wilson LA; Forrest J; Mills EJ; Hermans MP; Mulangu S; Ntoumi F; Zumla A; Muyembe-Tamfum JJ
    Am J Trop Med Hyg; 2023 Oct; 109(4):719-724. PubMed ID: 37580027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The outbreak of the monkeypox virus in the shadow of the pandemic.
    Majie A; Saha R; Sarkar B
    Environ Sci Pollut Res Int; 2023 Apr; 30(17):48686-48702. PubMed ID: 36854947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries.
    Quarleri J; Delpino MV; Galvan V
    Geroscience; 2022 Aug; 44(4):2095-2103. PubMed ID: 35726117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations.
    Frenois-Veyrat G; Gallardo F; Gorgé O; Marcheteau E; Ferraris O; Baidaliuk A; Favier AL; Enfroy C; Holy X; Lourenco J; Khoury R; Nolent F; Grosenbach DW; Hruby DE; Ferrier A; Iseni F; Simon-Loriere E; Tournier JN
    Nat Microbiol; 2022 Dec; 7(12):1951-1955. PubMed ID: 36344621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notes from the Field: Mpox Cluster Caused by Tecovirimat-Resistant Monkeypox Virus - Five States, October 2023-February 2024.
    Gigante CM; Takakuwa J; McGrath D; Kling C; Smith TG; Peng M; Wilkins K; Garrigues JM; Holly T; Barbian H; Kittner A; Haydel D; Ortega E; Richardson G; Hand J; Hacker JK; Espinosa A; Haw M; Kath C; Bielby M; Short K; Johnson K; De La Cruz N; Davidson W; Hughes C; Green NM; Baird N; Rao AK; Hutson CL
    MMWR Morb Mortal Wkly Rep; 2024 Oct; 73(40):903-905. PubMed ID: 39388389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monkeypox: A re-emerging disease.
    Kaur N; Dabar J; Bassi P
    Indian J Pharmacol; 2024 Mar; 56(2):129-135. PubMed ID: 38687317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer?
    Ezat AA; Abduljalil JM; Elghareib AM; Samir A; Elfiky AA
    Expert Opin Drug Discov; 2023 May; 18(5):551-561. PubMed ID: 37032577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 2022 human monkeypox outbreak: Clinical review and management guidance.
    Aldhaeefi M; Rungkitwattanakul D; Unonu J; Franklin CJ; Lyons J; Hager K; Daftary MN
    Am J Health Syst Pharm; 2023 Jan; 80(2):44-52. PubMed ID: 36259674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monkeypox Virus (MPXV) Infection: A Review.
    Kumari R; Arya P; Yadav SP; Mishra RC; Yadav JP
    Infect Disord Drug Targets; 2024; 24(4):76-82. PubMed ID: 38243966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human monkeypox infection threat: A comprehensive overview.
    Kang Y; Yu Y; Xu S
    PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011246. PubMed ID: 37079486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of monkeypox: a worldwide public health crisis.
    Begum JPS; Ngangom L; Semwal P; Painuli S; Sharma R; Gupta A
    Hum Cell; 2023 May; 36(3):877-893. PubMed ID: 36749539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antivirals With Activity Against Mpox: A Clinically Oriented Review.
    Siegrist EA; Sassine J
    Clin Infect Dis; 2023 Jan; 76(1):155-164. PubMed ID: 35904001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.